Financhill
Back

NewAmsterdam Pharma Co NV Vs. ProQR Therapeutics NV Industry Stock Comparison

Sell
46

NAMS
NewAmsterdam Pharma Co NV

Last Price:
$25.90
Seasonality Move:
37.93%
Sell
12

PRQR
ProQR Therapeutics NV

Last Price:
$2.76
Seasonality Move:
-17.34%
Sell
46
NewAmsterdam Pharma Co NV (NAMS) is a Sell

Is NewAmsterdam Pharma Co NV a Buy, Sell or Hold?

  • The current NewAmsterdam Pharma Co NV [NAMS] share price is $25.94. The Score for NAMS is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • NAMS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
12
ProQR Therapeutics NV (PRQR) is a Sell

Is ProQR Therapeutics NV a Buy, Sell or Hold?

  • The current ProQR Therapeutics NV [PRQR] share price is $2.76. The Score for PRQR is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
  • PRQR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

NAMS Stock Price Chart

What is NewAmsterdam Pharma Co NV's stock price today?

  • The NewAmsterdam Pharma Co NV share price today is $25.94
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NAMS is experiencing slight buying pressure.

PRQR Stock Price Chart

What is ProQR Therapeutics NV's stock price today?

  • The ProQR Therapeutics NV share price today is $2.76
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRQR is experiencing slight buying pressure.

NAMS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.2 Buy
Relative Strength Index (14 RSI): 62.17 Buy
Chaikin Money Flow: 112221 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.5 - 26.7) Buy
Bollinger Bands (100): (15.98 - 23.22) Buy

PRQR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 42.77 Sell
Chaikin Money Flow: 45157 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.62 - 3.5) Sell
Bollinger Bands (100): (1.9 - 3.54) Buy

NAMS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.86 Buy
20-day SMA: 24.58 Buy
50-day SMA: 22.37 Buy
200-day SMA: 19.72 Buy
8-day EMA: 25.74 Buy
20-day EMA: 24.72 Buy
50-day EMA: 22.69 Buy
200-day EMA: 19.45 Buy

PRQR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.7 Buy
20-day SMA: 2.91 Sell
50-day SMA: 3.35 Sell
200-day SMA: 2.33 Buy
8-day EMA: 2.73 Buy
20-day EMA: 2.9 Sell
50-day EMA: 3.02 Sell
200-day EMA: 2.5 Buy

NewAmsterdam Pharma Co NV Earnings Growth & NAMS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.26 per share, and an increase next year of $0.08 per share.

ProQR Therapeutics NV Earnings Growth & PRQR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.07 per share, and a decrease next year of $0.03 per share.

NewAmsterdam Pharma Co NV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

ProQR Therapeutics NV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):